News Aptahems VD interjuad av Mangold Insight 26 May, 2025
  • About Aptahem
    • Business Strategy
    • Business Model
    • History
    • Team
  • Portfolio
    • RNA-therapeutics
    • Apta-1
    • Apta-2
    • Apta-3
    • Intellectual Property and Patent
  • Our Research
    • Scientific Collaborations
      • Örebro Consortium
      • Seattle Children’s Research Institute (SCRI)
      • University Health Network (UHN)
    • Publications
    • Production
    • Mechanism of Action
  • About Sepsis
  • Investor
    • Rights Issue 2025
    • Market Potential
    • Company Information
    • Share information
    • General Meetings
    • Largest Owners
    • Financial Reports
      • Annual Reports
      • Interim Reports
    • Financial Calendar
    • Events
    • Share issues
    • Analyzes
    • Nomination Committee
  • Media
    • News
    • Newsletter
    • Presentations
    • Sepsis Seminar 2021
  • Contact
  • Svenska
  • About Aptahem
    • Business Strategy
    • Business Model
    • History
    • Team
  • Portfolio
    • RNA-therapeutics
    • Apta-1
    • Apta-2
    • Apta-3
    • Intellectual Property and Patent
  • Our Research
    • Scientific Collaborations
    • Publications
    • Production
    • Mechanism of Action
  • About Sepsis
  • Investor
    • Rights Issue 2025
    • Market Potential
    • Company Information
    • Share information
    • General Meetings
    • Largest Owners
    • Financial Reports
    • Financial Calendar
    • Events
    • Share issues
    • Analyzes
    • Nomination Committee
  • Media
    • News
    • Newsletter
    • Presentations
    • Sepsis Seminar 2021
  • Contact

Nomination Committee

The Nomination Committee for the AGM 2025 has been announced

Please see the information about the Nomination Committee (in Swedish) here.

Aptahem AB

Norra Vallgatan 58
211 22 Malmö
Sweden

E-mail: info@aptahem.com

Sociala medier

Facebook
LinkedIn

To all salespersons

We kindly decline all direct contact with salespersons of different types of products and services.

Copyright © 2025 Aptahem AB. All Rights Reserved. | Privacy Policy | Design by Clavis Communications.